Results

Total Results: 1,187 records

Showing results for "weeks".

161. Masks for Prevention of COVID-19 in Community and Healthcare Settings: Surveillance Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-surveillance-2-report.pdf
     October 01, 2020 - Chandler Weeks, M.P.H. Marian S. McDonagh, Pharm.D. … Suggested citation: Chou R, Dana T, Jungbauer R, Weeks C, McDonagh M.

162. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
     July 13, 2011 - direct head-to- head comparisons: double-blind, placebo-controlled RCTs Minimum study duration 6 weeks … Good or fair quality, controlled observational studies Minimum study duration For RCTs: 6 weeks … case-control studies, large database reviews) Uncontrolled trials Minimum study duration For RCTs: 6 weeks … Definition of Terms Acute Phase: first phase of depression management, usually 6 to 12 weeks in length

163. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - daily.7 Clinical trials: In a clinical trial of 52 patients, investigators reported that after 52 weeks … exposed to at least one dose of GATTEX (190 patient-years of exposure; mean duration of exposure was 17 weeks … After 24 weeks of treatment, 54% of patients treated with teduglutide reduced the number of infusion … used to increase nutrient absorption; however, somatropin has not been evaluated for longer than 4 weeks … Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal

164. Disposition of Comments Report for Biologic and Nonbiologic Systemic Agents and Phottherapy for Treatment of Chronic Plaque Psoriasis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
     November 27, 2012 - impossible to compare drugs over the long-term because if a given drug is not working at 12 or 16 weeks … If therapies are not working by 12-16 weeks, they will not work later. … Although therapies may be stopped after 12 to 16 weeks in patients who fail treatment, there are patients … who are on these therapies much longer than 16 weeks when therapies are successful. … We have provided the PASI for both 12 and 24 weeks.

165. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - daily.7 Clinical trials: In a clinical trial of 52 patients, investigators reported that after 52 weeks … exposed to at least one dose of GATTEX (249 patient-years of exposure; mean duration of exposure was 22 weeks … After 24 weeks of treatment, 53.8% of patients treated with teduglutide reduced the number of infusion … used to increase nutrient absorption; however, somatropin has not been evaluated for longer than 4 weeks … Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal

166. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - with placebo through week 24 (p<0.001).7 Effects on pulmonary function were observed as early as 2 weeks … authors, “Patients treated with ivacaftor had sustained improvements in FEV1 and weight up to 144 weeks … , the decrease in exacerbation rate compared with the prior placebo rate was maintained up to 144 weeks … of PERSIST and in 34 (23.6%) adults and 10 (20.8%) children during the subsequent 48 weeks. … of treatment (96 weeks of persist).

167. Restless-Legs Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
     November 01, 2012 - English, evaluated pharmacologic and/or nonpharmacologic interventions for RLS, lasted at least 4 weeks … this report is a comparative effectiveness review.17 Only two placebo-controlled trials lasted 24 weeks … or more,26,34 and none exceeded 28 weeks. … Cabergoline17 improved IRLS scores more than levodopa in a single trial lasting 30 weeks (n=361) among … Twelve 30-minute near-infrared light treatment sessions were applied over 4 weeks.

168. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - (for a total of 96 weeks of treatment). … In an interim analysis, after 48 total weeks of treatment with lumacaftor/ivacaftor, patients who had … for 32 weeks. … for 20 weeks in addition to their optimized steroid regimen. … of treatment); and -73.1 mL for patients initiating treatment with nintedanib (48 weeks of treatment

169. Antenatal Care | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/antenatal-care

170. Menopause-Protocol-130612 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
     June 12, 2013 - Osteoporotic fractures  Agent-specific adverse events • Timing Outcome assessment at least 12 weeks … RCTs should have at least 25 patients randomized per arm who are studied for at least 12 weeks; these … for RCTs should have at least 25 patients randomized per arm who are studied for at least 12 weeks … translates into similar efficacy at 12 weeks.56, 57 Source: www.effectivehealthcare.ahrq.gov … centrally acting agents (SSRI, SNRI, gabapentin, and pregabalin) minimum trial duration will be 4 weeks

171. Depression-Postpartum-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_executive.pdf
     May 01, 2013 - present during the same 2-week period, with a secondary criterion of onset of symptoms within 4 weeks … Other diagnostic standards allow the definition of onset to extend beyond 4 weeks and up to 12 months … The KQs were then 4 posted for public comment for 4 weeks from November 8 to December 6, 2011, … vs. 8 weeks to 6 months 1 (534) High NA Direct Imprecise Insufficient Delivery vs. 6 weeks 1 (113 … gestation or 6 weeks postpartum.

172. App-D-Opioid-Chronic-Pain-Surveill-Report-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
     September 30, 2015 - Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration: 6 weeks … , adjusted for race and depression) Pain severity (0 to 10): 7.15 (SD 2.38) vs. 7.36 (SD 1.55) at 9 weeks … difference -0.21 (95% CI -1.71 to 1.29)* Pain interference (0 to 70): 32.8 (SD 17.94) vs. 42.0 (10.71) at 9 weeks

173. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
     August 01, 2022 - therapy for outcomes related to pain, function, pain relief satisfaction, and quality of life up to 4 weeks … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks None Settings ED, physician’s office, hospital None Study design Original

174. Kidney-Disease-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
     October 01, 2012 - 227 Adults with CKD (GFR 20-45 ml/min/ 1.73 m2 BSA) Change from baseline in estimated GFR 52 weeks … Patients receiving bardoxolone methyl had significant increases in eGFR compared with placebo at 24 weeks … urinary albumin- to-creatinine ratio (UACR) of 100-3000 mg/g Change from baseline in UACR 8 weeks … Harcourt, 20118 Randomized crossover trial of 2 weeks each on a low and high AGE- containing … Renal function, inflammatory profile (MCP-1) and macrophage migration inhibitory factor (MIF) 4 weeks

175. Chronic-Cough Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_executive.pdf
     March 01, 2014 - Cough that lasts more than 4 weeks in children younger than 14 years of age or more than 8 weeks … The KQs were then posted for public comment in September 2011 for 4 weeks, and the comments received … We accepted as chronic any cough described as such, or that exceeded 8 weeks in adults and adolescents … or 4 weeks in children ≤14 years of age. … Thirty- three (33) studies (69 percent) had a followup duration of 2 weeks or less.

176. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - two oral DMARDs, improved ACR 50 response rates, disease activity scores, but no difference at 56 weeks … patients with early RA, significantly lower radiographic progression and fewer eroded joints at 56 weeks … but no differences by 56 weeks. … two oral DMARDs, improved ACR 50 response rates, disease activity scores, but no difference at 56 weeks … but no differences by 56 weeks.

177. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - two oral DMARDs, improved ACR 50 response rates, disease activity scores, but no difference at 56 weeks … patients with early RA, significantly lower radiographic progression and fewer eroded joints at 56 weeks … but no differences by 56 weeks. … two oral DMARDs, improved ACR 50 response rates, disease activity scores, but no difference at 56 weeks … but no differences by 56 weeks.

178. Ced -Appendix-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
     May 29, 2025 - Questions why comment period is only 3 weeks and outside the usual Notice and Comment period. … second comment period and CMS schedule a second MEDCAC meeting focused on the AHRQ CED analysis (3 weeks … Alliance for Regenerative Medicine Questions why comment period is only 3 weeks and outside the usual … second comment period and CMS schedule a second MEDCAC meeting focused on the AHRQ CED analysis (3 weeks

179. Leong-notes-151020 copy - Teresa (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/leong-presenation.pdf
     May 29, 2025 - The trips to the physician were grueling because it was a two hour trip every two weeks for 5 years. … The visits every two weeks never addressed that.

180. S44 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s44.pdf
     October 01, 2007 - Six months of de- layed savings in 10% of nebulized medication users would equal 2.5 weeks of delayed … After many months of delays, a further delay in savings equal to 2.5 weeks was tolerable to PharmaCare … Against our preference, PharmaCare sent the letter announcing the policy 6 weeks ahead to all physicians … Controls were told of their 6-month exemption 2 weeks later in a separate letter. … Just 6 weeks after the end of the 6-month delay, we presented preliminary findings at a scientific conference